Clinical Trial Industry Standard Research (ISR) IRT BENCHMARK SURVEY

20 February 2023 | Monday | News | By E.K. Koh Chief Product Officer Suvoda

Successfully implementing a complex clinical study requires not only flexibility in the clinical trial software, but also the ability to easily integrate with data systems and sponsor drug supply. It’s not surprising then that ease of integration is noted as the most important attribute in selecting an IRT partner…and by a wide margin.

We are pleased that Suvoda outperforms competing IRT providers in three key areas: speed of data integration; integrations with eClinical tech solutions including EDC, ePRO, CTM, and others; and integrations with sponsor drug supply.

With the introduction of our new Suvoda Platform things are getting even better. Customers benefit from three already-integrated solutions–eConsent, IRT, and eCOA–while our comprehensive API surface reduces integration friction with third-party solutions and sponsor systems.

For sponsors and site users this means spending less time on technology and more time focusing on uncovering new therapeutics to benefit patients.

Learn more about how the Suvoda Platform reduces and simplifies integrations.

Clinical Trial Industry Standard Research (ISR) IRT BENCHMARK SURVEY

Stay Connected